Rare diseases
Investigational molecules
Locations
Back to Spain316 clinical trials in Alicante, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
SpainA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
SpainStudy of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis
SpainPhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
SpainCabotegravir and Rilpivirine Ultra‑Long‑Acting vs Long‑Acting in Adults and Adolescents with HIV Who Are Virally Suppressed
SpainEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
SpainSafety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)
SpainPhase 2 Neoadjuvant Study of Amivantamab with Lazertinib in Resectable EGFR‑Mutated Non‑Small Cell Lung Cancer Patients
SpainSwitching to lenacapavir-based drug combination vs cabotegravir-based drug combination in virologically suppressed adults with HIV-1
SpainStudy of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive
SpainA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
SpainRemibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial
SpainThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on advanced treatments for non-small cell lung cancer, including both early-stage and metastatic cases. Investigations are ongoing in acute myeloid leukemia and lymphoma treatments.
Research emphasizes innovative combination therapies and targeted treatments for better patient outcomes.
Comprehensive research into treatments for plaque psoriasis and atopic dermatitis, with multiple trials evaluating new therapeutic approaches for moderate to severe cases.
Studies focus on developing effective solutions for chronic skin conditions.
Investigations into hypertrophic cardiomyopathy and post-heart attack treatments, including studies on specialized stent therapies and antiplatelet medications.
Focus on improving outcomes for patients with various cardiac conditions.
Clinical trials examining treatments for allergic rhinoconjunctivitis and responses to various allergens, including specialized immunotherapy approaches.
Research aims to improve allergy management and treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
